Home Cart Sign in  
Chemical Structure| 870281-34-8 Chemical Structure| 870281-34-8

Structure of Acalisib
CAS No.: 870281-34-8

Chemical Structure| 870281-34-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Acalisib is a potent and selective inhibitor of PI3Kδ with IC50 value of 12.7 nM.

Synonyms: GS-9820; CAL-120

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Acalisib

CAS No. :870281-34-8
Formula : C21H16FN7O
M.W : 401.40
SMILES Code : O=C1N(C2=CC=CC=C2)C([C@@H](NC3=C4N=CNC4=NC=N3)C)=NC5=C1C=C(F)C=C5
Synonyms :
GS-9820; CAL-120
MDL No. :MFCD28411423
InChI Key :DOCINCLJNAXZQF-LBPRGKRZSA-N
Pubchem ID :11618268

Safety of Acalisib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Acalisib

PI3K-AKT

Isoform Comparison

Biological Activity

Target
  • p110δ

    p110δ, IC50:14 nM

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01705847 Lymphoid Malignancies PHASE1 COMPLETED 2025-05-16 VU Medical Center (VUmc), Amst... More >>erdam, 1081 HV, Netherlands|Academic Medical Center, Amsterdam, 1105 AZ, Netherlands|St. Antonius Hospital, Nieuwegein, 3435 CM, Netherlands|Erasmus MC - Daniel den Hoed Cancer Center, Rotterdam, 3075 EA, Netherlands Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.49mL

0.50mL

0.25mL

12.46mL

2.49mL

1.25mL

24.91mL

4.98mL

2.49mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories